ApoA1 polyclonal, anti-human, mouse, rat

Protein Family: Transporters

Pathway and Disease: Endocrine System, Infectious Diseases, Lipid Metabolism

Description:
Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma. ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion. It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters. Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis.

Alternate Names: ApoA1, Apolipoprotein A1, ApoAI

Application Notes: E: 1:500-1:1,000; WB: 1:100-1:500; IF: 1:100-1:500

Accession No.: P02647

Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of human ApoA1.

Format: Each vial contains 0.1 ml IgY (1 mg/ml) in PBS pH 7.4 with 0.02% sodium azide. Antibody was purified by immunogen affinity chromatography.

Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.